- Home
- GALT vs VMD Comparison
GALT vs VMD Comparison
Compare GALT & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GALT | VMD |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 351.6M |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GALT | VMD |
|---|---|---|
| Price | $3.64 | $9.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | 234.5K | ★ 236.7K |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | 32.14 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $270,280,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | N/A | $11.23 |
| P/E Ratio | ★ N/A | $72.15 |
| Revenue Growth | N/A | ★ 20.52 |
| 52 Week Low | $2.03 | $6.05 |
| 52 Week High | $7.13 | $12.61 |
Technical Indicators
Market Signals| Indicator | GALT | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 61.39 |
| Support Level | $3.58 | $9.26 |
| Resistance Level | $4.30 | $10.05 |
| Average True Range (ATR) | 0.21 | 0.23 |
| MACD | -0.04 | 0.10 |
| Stochastic Oscillator | 17.81 | 89.89 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.